Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Goldberg Officer	$134.64	1,200	$161,568.00	85,911	2012-05-02	Filing
Schleifer Officer, Director	$136.57	100	$13,657.00	286,328	2012-05-01	Filing
Schleifer Officer, Director	$135.29	39,106	$5,290,650.74	286,428	2012-05-01	Filing
Schleifer Officer, Director	$134.55	58,494	$7,870,367.70	325,534	2012-05-01	Filing
Schleifer Officer, Director	$133.86	2,300	$307,878.00	384,028	2012-05-01	Filing
Yancopoulos Officer, Director	$135.29	12,945	$1,751,329.05	833,041	2012-05-01	Filing
Yancopoulos Officer, Director	$134.54	20,120	$2,706,944.80	845,986	2012-05-01	Filing
Yancopoulos Officer, Director	$133.95	100	$13,395.00	866,106	2012-05-01	Filing
Aberman Officer	$135.29	2,300	$311,167.00	10,000	2012-05-01	Filing
Aberman Officer	$134.52	3,862	$519,516.24	12,300	2012-05-01	Filing
Van Officer	$136.42	13,143	$1,792,968.06	9,568	2012-04-30	Filing
Van Officer	$135.94	1,299	$176,586.06	22,711	2012-04-30	Filing
Baker Director	$125.00	12,910	$1,613,750.00	9,590	2012-04-19	Filing
Baker Director	$125.00	2,090	$261,250.00	9,590	2012-04-17	Filing
Yancopoulos Officer, Director	$121.09	1,010	$122,300.90	866,206	2012-03-26	Filing
Yancopoulos Officer, Director	$120.21	32,140	$3,863,549.40	867,216	2012-03-26	Filing
Goldstein Director	$120.00	5,000	$600,000.00	0	2012-03-26	Filing
Goldstein Director	$115.00	5,000	$575,000.00	0	2012-03-15	Filing
Goldstein Director	$111.06	400	$44,424.00	0	2012-03-15	Filing
Goldstein Director	$110.77	4,600	$509,542.00	0	2012-03-15	Filing